Video

AML Treatment Selection: Goals, Tests, and Considerations

Cole McCoy, PharmD, and James McCloskey, MD, explain common treatment goals, cytogenetic tests, and considerations that factor into choosing individualized treatment for patients with AML.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
3 experts are featured in this series.
Related Content
Patient self-administering subcutaneous injection | Image Credit: © - stock.adobe.commanusapon
September 4th 2025

Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma

Alexandra Gerlach, Associate Editor
pharmacy focus oncology edition
September 4th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
CAR T-cell therapy injected into tumor cell 3D visualization | Image Credit: © john - stock.adobe.com
September 4th 2025

Targeted Therapy Brings Remission in Patient With CAR-Positive T-Cell Lymphoma

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
September 4th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Ibrutinib, Imbruvica tablets | Image Credit: © CLShebley - stock.adobe.com
September 4th 2025

Ibrutinib–Venetoclax Outperforms Ibrutinib Alone and FCR in Long-Term CLL

Alexandra Gerlach, Associate Editor
Immunoglobulin in IV | Image Credit: © Trsakaoe - stock.adobe.com
September 4th 2025

Immunoglobulin Replacement Therapy Fails to Lower Hospitalizations in CLL, Study Finds

Alexandra Gerlach, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.